Product NDC: | 65862-401 |
Proprietary Name: | Divalproex Sodium |
Non Proprietary Name: | Divalproex Sodium |
Active Ingredient(s): | 125 mg/1 & nbsp; Divalproex Sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65862-401 |
Labeler Name: | Aurobindo Pharma Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090554 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110421 |
Package NDC: | 65862-401-71 |
Package Description: | 7000 TABLET, DELAYED RELEASE in 1 BOTTLE (65862-401-71) |
NDC Code | 65862-401-71 |
Proprietary Name | Divalproex Sodium |
Package Description | 7000 TABLET, DELAYED RELEASE in 1 BOTTLE (65862-401-71) |
Product NDC | 65862-401 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Divalproex Sodium |
Dosage Form Name | TABLET, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20110421 |
Marketing Category Name | ANDA |
Labeler Name | Aurobindo Pharma Limited |
Substance Name | DIVALPROEX SODIUM |
Strength Number | 125 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |